Antidepressant utilization in British Columbia from 1996 to 2004: Increasing prevalence but not incidence

Psychiatric Services

Volumn 58, Issue 1, 2007, Pages 79-84

  Raymond, Colette B ^a   Morgan, Steven G ^b   Caetano, Patricia A ^b  

^a HEALTH SCIENCES CENTRE   (Canada)

^b Health Sciences Centre Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; TRYPTOPHAN; VENLAFAXINE;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG UTILIZATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INCIDENCE; MALE; MEDICAL SERVICE; PRESCRIPTION; PREVALENCE; REGISTRATION; SMOKING CESSATION; SOCIOECONOMICS;

EID: 33847010164     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2007.58.1.79     Document Type: Article

References (43)

1. Leading Therapy Classes by Global Pharmaceutical Sales, 2004. IMS Health. Available at www.imshealth.com/ims/portal/front/articleC/0,2777, 659971234024712341 09,00.html. Accessed July 31, 2006
2. Guaiana G, Andretta M, Corbari L, et al: Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. Journal of Clinical Psychiatry 66:750-755, 2005
3. Hemels ME, Koren G, Einarson TR: Increased use of antidepressants in Canada: 1981-2000. Annals of Pharmacotherapy 36:1375-1379, 2002
4. Isacsson G, Boethius G, Henriksson S, et al: Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations: findings from a Swedish prescription database. Journal of Affective Disorders 53:15-22, 1999
5. Mamdani M, Rapoport M, Shulman KI, et al: Mental health-related drug utilization among older adults: prevalence, trends, and costs. American Journal of Geriatric Psychiatry 13:892-900, 2005
6. Mamdani MM, Parikh SV, Austin PC, et al: Use of antidepressants among elderly subjects: trends and contributing factors. American Journal of Psychiatry 157:360-367, 2000
7. Mant A, Rendle VA, Hall WD, et al: Making new choices about antidepressants in Australia: the long view 1975-2002. Medical Journal of Australia 181(suppl):S21-S24, 2004
8. Middleton N, Gunnell D, Whitley E, et al: Secular trends in antidepressant prescribing in the UK, 1975-1998. Journal of Public Health and Medicine 23:262-267, 2001
9. Poluzzi E, Motola D, Silvani C, et al: Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement. European Journal of Clinical Pharmacology 59:825-831, 2004
10. Rosholm JU, Gram LF, Isacsson G, et al: Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study. European Journal of Clinical Pharmacology 52:205-209, 1997
11. Rosholm JU, Andersen M, Gram LF: Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. European Journal of Clinical Pharmacology 56:923-929, 2001
12. Van Eijk ME, Bahri P, Dekker G, et al: Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects. Journal of Clinical Epidemiology 53:645-651, 2000
13. Roberts E, Norris P: Growth and change in the prescribing of anti-depressants in New Zealand: 1993-1997. New Zealand Medical Journal 114:25-27, 2001
14. Olfson M, Marcus SC, Druss B, et al: National trends in the outpatient treatment of depression. JAMA 287:203-209, 2002
15. Lawrenson RA, Tyrer F, Newson RB, et al: The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. Journal of Affective Disorders 59:149-157, 2000
16. Pirraglia PA, Stafford RS, Singer DE: Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. Primary Care Companion to the Journal of Clinical Psychiatry 5:153-157, 2003
17. Fricchione G: Clinical practice: generalized anxiety disorder. New England Journal of Medicine 351:675-682, 2004
18. Stein MB: Advances in recognition and treatment of social anxiety disorder: a 10-year retrospective. Psychopharmacology Bulletin 37(suppl 1):97-107, 2003
19. Sindrup SH, Otto M, Finnerup NB, et al: Antidepressants in the treatment of neuropathic pain. Basic and Clinical Pharmacology and Toxicology 96:399-409, 2005
20. Hughes J, Stead L, Lancaster T: Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews CD 000031, 2004
21. Freeman EW: Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder. Pharmacoeconomics 23:433-444, 2005
22. Stone KJ, Viera AJ, Parman CL: Off-label applications for SSRIs. American Family Physician 68:498-504, 2003
23. Kravitz RL, Epstein RM, Feldman MD, et al: Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 293:1995-2002, 2005
24. Judd LL, Paulus MJ, Schettler PJ, et al: Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? American Journal of Psychiatry 157:1501-1504, 2000
25. Patten SC: The duration of major depressive episodes in the Canadian general population. Chronic Diseases in Canada 22:6-11, 2001
26. Kennedy SH, Lam RW, Cohen NL, et al: Clinical guidelines for the treatment of depressive disorders. IV: medications and other biological treatments. Canadian Journal of Psychiatry 46(suppl 1):38S-58S, 2001
27. Mann JJ: The medical management of depression. New England Journal of Medicine 353:1819-1834, 2005
28. Geddes JR, Freemantle N, Mason J, et al: SSRIs versus other antidepressants for depressive disorder. Cochrane Database of Systematic Reviews CD001851, 2000
29. Williams JW Jr, Mulrow CD, Chiquette E, et al: A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Annals of Internal Medicine 132:743-756, 2000
30. Hebert S: Bupropion (Zyban, sustained-release tablets): reported adverse reactions. Canadian Medical Association Journal 160:1050-1055, 1999
31. Choi S: Nefazodone (Serzone) withdrawn because of hepatotoxicity. Canadian Medical Association Journal 169:1187, 2003
32. Nutt DJ: Death and dependence: current controversies over the selective serotonin reuptake inhibitors. Journal of Psychopharmacology 17:355-364, 2003
33. Fergusson D, Doucette S, Glass KC, et al: Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. British Medical Journal 330:396, 2005
34. Krueger KP, Berger BA, Felkey B: Medication adherence and persistence: a comprehensive review. Advances in Therapy 22:313-356, 2005
35. Maddox JC, Levi M, Thompson C: The compliance with antidepressants in general practice. Journal of Psychopharmacology 8:48-53, 1994
36. Percudani M, Barbui C, Fortino I, et al: Antidepressant drug prescribing among elderly subjects: a population-based study. International Journal of Geriatric Psychiatry 20:113-118, 2005
37. Beck CA, Patten SB, Williams JV, et al: Antidepressant utilization in Canada. Social Psychiatry and Psychiatric Epidemiology 40:799-807, 2005
38. Fransoo R, Martens P, Burland E, et al: Sex Differences in Health Status, Health Care Use, and Quality of Care: A Population-Based Analysis for Manitoba's Regional Health Authorities. Winnipeg, MB, Manitoba Centre for Health Policy, 2005
39. Martens P, Fransoo R, Burland E, et al: The Manitoba RHA Indicators Atlas: Population-Based Comparison of Health and Health Care Use. Winnipeg, MB, Manitoba Centre for Health Policy, 2003
40. Barbui C, Broglio E, Laia AC, et al: Cross-sectional database analysis of antidepressant prescribing in Italy. Journal of Clinical Psychopharmacology 23:31-34, 2003
41. Pietraru C, Barbui C, Poggio L, et al: Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database. European Journal of Clinical Pharmacology 57:605-609, 2001
42. Marmot MG, Shipley MJ, Rose G: Inequalities in death - specific explanations of a general pattern? Lancet 1:1003-1006, 1984
43. Marmot MG, Kogevinas M, Elston MA: Social/economic status and disease. Annual Review in Public Health 8:111-135, 1987